mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |